Jonathan W. Engle

University of Wisconsin–Madison — United States

Medicine · Health Sciences

54h-index10.0kcitations436works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(183), Medical Imaging Techniques and Applications(74), Nuclear Physics and Applications(47), Prostate Cancer Treatment and Research(36), Medical Imaging and Pathology Studies(35)

Publications433 total

Prenatal Stress and Prenatal Alcohol Alter the Adult Dopamine System and Alcohol Consumption: Dopamine Drives Drinking Behavior in a Prospective 20-Year Longitudinal Experiment with Rhesus Macaques
Journal of Neuroscience·2026Open Access
A MET-Targeted Variable New Antigen Receptor (VNAR) Theranostic for Non-Small Cell Lung Cancer
2026Open Access
Improved X-ray absorption capability of Core-shell nano-transducer in situ enhances γ-ray-excited radioluminescence imaging in vivo
Journal of Nanobiotechnology·2026Open Access
<p>Small Cyclotron Production of Non-Carrier-Added 103Pd from Electroplated Rh Targets</p>
SSRN Electronic Journal·2026Open Access
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors
Radiation·2025Open Access
Evaluation of Bifunctional, PSMA-Targeted Triazamacrocycle-Picolinates Compatible with the <sup>18</sup> F/ <sup>44</sup> Sc/ <sup>177</sup> Lu Isotope Triad
Journal of Medicinal Chemistry·2025Open Access
A Trifunctional, Rare-Earth Theranostic Chelator Platform to Enable Diagnostic Nuclear Imaging, Surgical Resection, and Radiotherapy
Journal of the American Chemical Society·2025· 1 citedOpen Access
Figure S1 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
2025Open Access
Figure S4 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
2025Open Access
Figure S3 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
2025Open Access
Figure S2 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
2025Open Access
Noninvasive Evaluation of Trop2 Expression Using <sup>64</sup> Cu-NOTA-Trodelvy-F(ab’) <sub>2</sub> in Gastric and Pancreatic Cancer
Molecular Pharmaceutics·2025Open Access
Production of 77Br using the GE PETtrace Solid Target Platform
Nuclear Medicine and Biology·2025
Preclinical Studies for Novel Theranostic Radiopharmaceutical 3-[76Br/77Br]bromo-pHPG
Nuclear Medicine and Biology·2025
Cyclotron-Produced [51Mn]MnCl2 PET/MR Detects Surgically Induced Neuropathic Pain in Rats
Nuclear Medicine and Biology·2025Open Access
Cyclotron-produced 206Bi for SPECT evaluation of 225Ac and 212Pb daughters’ redistribution in vivo
Nuclear Medicine and Biology·2025Open Access
Chemical Tools to Characterize the Coordination Chemistry of Radionuclides for Radiopharmaceutical Applications
Chemical Reviews·2025· 2 citedOpen Access
A-136 Rivaroxaban Anti-Xa Assay Validation as a Laboratory Developed Test on an Automated Coagulation Analyzer
Clinical Chemistry·2025Open Access
[<sup>44</sup>Sc]Sc-CHX-A″-DTPA-RCCB6: A PET Tracer for Imaging CD70 Expression Across Latency Types of Burkitt Lymphoma
Journal of Nuclear Medicine·2025Open Access
Separation of terbium from proton-irradiated gadolinium oxide targets – development of an effective, scalable and automatable process
Applied Radiation and Isotopes·2025
page 1 of 22Next →

Frequent Co-authors

Weibo Cai(32), Todd E. Barnhart(22), Dawei Jiang(15), Dalong Ni(12), Hao Hong(10), Yunan Yang(10), Christopher J. Kutyreff(8), Zachary T. Rosenkrans(8), Robert J. Nickles(8), Peng Huang(7), Carolina A. Ferreira(6), Emily B. Ehlerding(6), Bo Yu(5), Tuanwei Sun(5), Xiaoli Lan(5), F.M. Nortier(5), Eva R. Birnbaum(5), Gregory Severin(5), Yin Zhang(4), Shreya Goel(4)